Novavax Inc. on Aug. 5 again delayed the company’s timeline for seeking U.S. authorization for its two-dose Covid-19 vaccine, but expects to become a major distributor to lower and middle-income countries this year.
The Delta variant of the coronavirus is the cause of more than 80 percent of new U.S. Covid-19 cases, but the authorized vaccines remain more than 90 percent effective in preventing hospitalizations and deaths, said top U.S. infectious disease expert Anthony Fauci during a U.S. Senate hearing on July 20.
Sanofi SA and GlaxoSmithKline Plc received an approval from Indian authorities for a late-stage clinical trial of their protein-based Covid-19 vaccine candidate, the drugmakers said on July 8.
India’s Covid-19 deaths relative to infections hit a record high in June after cases peaked in early May, an analysis of government data shows, amid pressure on authorities to accurately report deaths from a second wave of the virus.
The Pfizer-BioNTech vaccine is highly effective against the Delta variant of Covid-19, a Pfizer official in Israel said on June 24.
Covid-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the Covid-19 causing virus that were first identified in India, according to a scientific study, underpinning a continued push to deliver the shots.
The University of Oxford is testing the anti-parasitic drug ivermectin as a possible treatment for Covid-19, as part of a British government-backed study that aims to aid recoveries in non-hospital settings.
The Delta variant of the novel coronavirus that was first found in India is the greatest threat to the United States’ effort to eradicate Covid-19 in the country’s borders, said U.S. infectious disease expert Dr. Anthony Fauci during a press call.
The Delta variant of Covid-19 – first identified in India – is becoming the globally dominant variant of the disease, the World Health Organization’s chief scientist said on June 18.
Coronavirus-related deaths worldwide passed a grim milestone of 4 million on June 17, according to a Reuters tally, as many countries struggle to procure enough vaccines to inoculate their populations.